Levine Media Group

Kannan Raman of Amazon Web Services (AWS) sits down with Amar Drawid, Ph.D. to discuss the role of AI in transforming life sciences and the importance of data strategy being tied to business outcomes. They explore the challenges of data strategy, the importance of cultural shifts within organizations, and the monetization of data as a product. https://lnkd.in/g4qua-Rt

Lishan Aklog, chairman and CEO of Lucid Diagnostics, discusses his company’s test to detect esophageal cancer, how it works, and its potential to change outcomes for people with the condition by catching it before it turns into a deadly cancer. https://lnkd.in/gYSad9WH

Frederic Revah, CEO of Genethon, discusses Duchenne muscular dystrophy, the organization’s efforts to complete clinical development of its gene therapy for the condition, and how it might commercialize the treatment. Global Genes https://lnkd.in/ga-MuV98

Two former Bay Area biotech execs--Menghis Bairu, MD and Richard Chin--are working to bring affordable biosimilars to Africa through their Bio Usawa. Read about the company's latest deal with the government of Rwanda to establish a biomanufacturing facility. https://lnkd.in/gVcbFx_T

Roy Maute, cofounder and CEO of Pheast Therapeutics, discusses how tumors evade the innate immune system, the company’s experimental macrophage checkpoint inhibitors, and its initial focus on ovarian and triple negative breast cancer. https://lnkd.in/gQ_Gqhiv

James G. Robinson, author of "More than We Expected: Five Years with a Remarkable Child," discusses his experience as the father of a child with a rare disease, life in hospital wards across two continents, and the feeling of pride in his son that remains after his death. Global Genes https://lnkd.in/gagwNMwF

The increasing demand for AI talent in the life sciences industry is presenting a challenge for biopharma HR departments. Companies must compete for skilled workers not only against their competitors but also against tech firms that often offer more attractive compensation packages. Steven Swan, CEO of The Swan Group, sat down with Amar Drawid, Ph.D. to discuss the current recruitment landscape for AI talent in the life sciences sector, the challenges companies are encountering, and why the mission of drug developers might give them a competitive advantage over tech companies in appealing to certain candidates. https://lnkd.in/gtjyC_CB

Samir Ounzain, co-founder and CEO of HAYA Therapeutics, discusses the potential to exploit the dark genome to treat diseases and the company’s collaboration with Eli Lily to use Haya’s platform technology to discover therapies for obesity and related metabolic conditions. https://lnkd.in/ghg8Y3kq

Mitochondria have been implicated in a wide range of diseases from birth to old age, but despite their essential role in health and disease, there is little effort to organize research into mitochondria and recognize it as a unique field of medicine. We spoke to Navdeep Chandel, Professor of Medicine, and Biochemistry & Molecular Genetics at Northwestern University - The Feinberg School of Medicine and a member of the mitoworld.org Scientific Advisory Board, about the state of mitochondrial research, the need to organize the research enterprise to address fundamental questions, and why doing so could help drive collaboration and funding to advance the field. https://lnkd.in/gzhuZEFC

Noam Baumatz, co-founder and CEO of NOGA Therapeutics, discusses his experience with a daughter born with a rare immunodeficiency, how that led to the founding of the gene therapy company Noga Therapeutics, and the company’s business decision to pursue both rare and common diseases. Global Genes #RARECast https://lnkd.in/g3J6R5uu